Page 62 of 73
Animal Health News & Notes for November 26, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 26, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: Virbac Corporation other news: Conagra Foods, Inc. (Pilgrim’s Pride) Conagra Foods, Inc. (UAP) eMerge Interactive, Inc. Hacco Hess & Clark Kyoto Boeki Kaisha Neogen Corporation Pilgrim’s Pride Triad Specialty Products Tyson Foods, Inc. UAP (ConAgra) UAP (Neogen) ******************************************************************** Upcoming Industry Events in 2004 please visit our website calendar for links to many of these events. January 12 Brakke Consulting 2004 US Animal Health & Nutrition Overview NYC 17-21 North American Veterinary Conference 28-30 International Poultry Expo 28-31 Cattle Industry Annual Convention & Trade Show 28-1 PIDA Management Conference & Annual Mtg February 08-10 AAFP Winter Conference 15-19 Western Veterinary Conference 26-29 Midwest Veterinary Conference 28-29 PIDA PETS 2004 March 01-5 AFIA Spring Forum 05-7 Malaysia Int’l Pet Expo 2004 06-9 AASP Annual Meeting 17-19 APPMA Annual Pet Products Trade Show 20-24 AAHA Annual Meeting 29-31 Pet Food Forum April 16-18 HH Backer Pet Industry Spring Trade Show 13-16 Interzoo 16-18 AVDA Meeting June 09-12 ACVIM Meeting 10-12 World Pork Expo 16-20 Southeast Veterinary Conference July 07-10 Canadian VMA Convention 24-28
;
November 26, 2003
Animal Health News & Notes for November 21, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 21, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: Central Garden & Pet PETCO PETsMART Smithfield Webster Veterinary Supply other news: Acrux Alltech AVANT Bayer Cross Vetpharm Dow AgroSciences DRAXIS Health Elanco (transdermal) Elanco (Merial) Export Packers Company Farmland GangaGen Grampian IDEXX Kalchem Int’l Lohmann AH Merial MetaFarms Novartis PETCO Royal Canin Smithfield St. Merryn Tabor Home Medical Services Tyson Foods Vita Plus ******************************************************************** COMPANY EARNINGS RELEASES > PETsMART, Inc. announced results for its third quarter, which ended November 2, 2003. The company reported third quarter net income of $29.6 million compared with the third quarter of last year when the company reported net income of $20.6 million. Net sales for the third quarter of 2003 were $734 million, compared to $657 million for the same period in 2002. Comparable store sales grew 7.5%, on top of 9.0% comparable store sales growth in the third quarter last year. Pet services sales for the third quarter were $46.8 million, up 27% over the third quarter of last year, an increase that reflects the company’s success in developing services that are attracting
;
November 21, 2003
Animal Health News & Notes for November 14, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 14, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: BASF Bayer Ceva Sante Animale Heska Premium Standard Farms Synbiotics Tyson Foods other news: APPMA Advanced ID Ag Services of America Bestmeat Heska NFZ Natural Fields Nutro Sergeant’s ******************************************************************** COMPANY EARNINGS RELEASES > Bayer reported net sales for the third quarter of 2003 for its animal health division were 204 million euros ($237 million), a decrease of 9% (1% in local currencies) compared to the third quarter of 2002. Operating result was 43 million euros ($50 million), a decrease of 16% compared to the third quarter of 2002. Sales for the first nine months of 2003 were 597 million euros ($692 million), a decrease of 6% (increase of 6% in local currencies) compared to the comparable period in 2002. Operating result for the nine months of 2003 were 128 million euros ($148 million), a decline of 11% compared to the comparable period in 2002. The declines in sales were mainly attributable to unfavorable currency effects. (company website) top > Ceva Sante Animale announced that turnover in the animal health
;
November 14, 2003
Animal Health News & Notes for November 7, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for November 7, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: Clorox Degussa Embrex OurPet’s Company Pilgrim’s Pride Virbac SA other news: Bayer AG Cargill Degussa Flexi-Mat Focus Technologies HomeMedVet IAMS Injectile Technologies Intervet VetInsite VPL Waltham ******************************************************************** COMPANY EARNINGS RELEASES > Virbac SA reported financial results for the third quarter 2003. Provisional net sales were 87 million euros ($100 million), a decline of 1.7% compared to the third quarter of 2002. After a slow down of the growth in July and August due to unfavorable climatic conditions in Europe, which have particularly penalized the Food Producing Animal Business, a strong recovery was registered in September in all activities and geographic areas. Provisional net sales for the first nine months of 2003 were 270 million euros ($313 million), a decrease of 0.8% compared to the comparable period in 2002, but an increase of 7.1% at a constant exchange rate and excluding acquisitions and the impact of expiration of food distribution agreements for companion animals. In the first 9 months of the year, the Companion Animal segment grew by 8.2% (proforma at constant
;
November 7, 2003
Animal Health News & Notes for October 31, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for October 31, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: Alpharma Doane Pet Care ImmuCell Merial other news: ConAgra Farmland Farnam Large Scale Biology Meow Mix Multimin USA National Beef Novus Int’l Phibro AH Schering-Plough Smithfield Solutia United Agri Products VCA Veterinary Product Laboratories ******************************************************************** COMPANY EARNINGS RELEASES > Aventis reported that sales by the Merial animal health joint venture were 470 million euros ($545 million) in the third quarter of 2003, up 12% from the year-ago period on an activity basis. This includes the poultry genetics business. > Alpharma reported that third quarter 2003 revenues for its animal health division declined to $74 million, a decline of 13% compared to $85 million in 2002. Revenue declines reflect increased competition in the swine and cattle segments. Sales for the first nine months of 2003 were $210 million, compared to $234 million in the comparable period in 2002. (company press release). > Doane Pet Care Company reported results for its third quarter and nine months ended September 27, 2003. For the three months ended September 27, 2003, the Company’s net
;
October 31, 2003
Animal Health News & Notes for October 24, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for October 24, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: earnings: Elanco eMerge Interactive Fort Dodge Hill’s IDEXX Intervet Land O’Lakes Nestlé Novartis Pfizer Schering-Plough VCA Antech other news: Bioniche Life Sciences DSM Embrex Farms.com Monsanto Novartis Animal Vaccines Pfizer (STOMP PLUS) Pioneer Hi-Bred Int’l Roche VeriPrime ******************************************************************** COMPANY EARNINGS RELEASES > Pfizer reported that revenues for its animal health division for the third quarter 2003 were $438 million, an increase of 56% which reflects Pfizer’s acquisition of Pharmacia in the first quarter of 2003. (Sales for both Pharmacia and Pfizer in the third quarter of 2002 were $411 million, which is a 7% increase in revenues for the combined companies.) The company noted that strong performances by companion animal products Revolution and Clavamox/Synulox, and by the livestock medicine RespiSure/Stellamune and cattle biologicals, contributed to the division’s performance. Revenues for the first nine months of 2003 were $1,090 million, an increase of 37% over the comparable period in 2002. (company website) top > Akzo Nobel reported results for the third quarter and first nine months of 2003 for animal healthcare business
;
October 24, 2003
Animal Health News & Notes for October 17, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for October 17, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* IN THE NEWS: Alcide (earnings) Banfield Bayer CropScience Farmland GeneThera Heska Labelclick Monsanto Organic BreadBasket Schering-Plough Smithfield Synbiotics Europe ******************************************************************* COMPANY EARNINGS RELEASES > Alcide Corporation released financial results for its fiscal first quarter ended Aug. 31, 2003. Alcide earned $92,767 on total revenue of $5.2 million during the quarter ended Aug. 31, 2003. In the first quarter a year ago, Alcide earned $61,669 on revenues of $5.0 million. (Business Wire) ******************************************************************** BRAKKE CONSULTING ANNOUNCES NEW STUDY NUTRITIONAL GROWTH ENHANCERS The debate on the use of non-therapeutic use of antibiotics in animal feed has in the past few years has increased the emphasis on the possible use of “natural” products as a possible replacement. Several years ago Brakke Consulting, Inc. issued a report on Direct Fed Microbial products and Enzymes as part of this group of natural products. We have now updated those sections and added two more — acidifiers and botanicals — to make a more complete report. The report answers the following questions: – Has the increased emphasis on these products led to a dramatic sales increase? The report details sales by product group, species and global region. – Who are the main players involved in this business? The report
;
October 17, 2003
Animal Health News & Notes for October 10, 2003
******************************************************************* Brakke Consulting’s Animal Health News & Notes for October 10, 2003 Copyright © Brakke Consulting, Inc. ******************************************************************* You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. JUMP TO: APEIS AgInfoLink Cargill Digital Angel eMerge Interactive Farmland IMI Global Merial Micro Beef Technologies Qiagen Smithfield Foods Swift & Co (earnings) Veterinary Products Laboratories ******************************************************************* COMPANY EARNINGS RELEASES > Swift & Co. reported results for its first fiscal quarter 2004 ended August 24, 2003. Net sales rose 16% to $2.48 billion, while first-quarter earnings before interest, taxes, depreciation and amortization rose 87% to $95.2 million. The company’s Swift Beef unit posted first-quarter operating income up 42% to $62.1 million, while Swift Pork posted a 187% rise in operating income to $14.7 million. (Meating Place) ******************************************************************* COMPANY NEWS RELEASES > QIAGEN N.V. and Merial Limited announced that Merial has acquired the assets of QIAGEN’s Pecura business acquired and developed by QIAGEN. The technology portfolio of the Pecura division includes the veterinary rights to a novel class of drugs that are based on immunostimulatory dinucleotides, which are believed to have promising potential in veterinary applications for livestock and companion animals. Pecura has an exclusive license from Coley Pharmaceutical Group, Inc. for the use of the
;
October 10, 2003
Animal Health News & Notes for October 3, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for October 3, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Farnam First Priority (copper naphthenate) First Priority (pyrantel) Fort Dodge Heska Lallemand Phoenix Scientific Veterinary Products Laboratories Veterinary Laboratories Vétoquinol ******************************************************************** COMPANY NEWS RELEASES > The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Heska Corp. The ANADA provides for use of chewable tablets containing ivermectin and pyrantel pamoate for prevention of heartworm disease and for treatment and control of certain gastrointestinal parasites in dogs. (AnimalNet – Federal Register) > The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA provides for oral use of two strengths of pyrantel pamoate suspension in dogs for the management of various internal parasites. (AnimalNet – Federal Register) > The FDA amended the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by First Priority, Inc. The ANADA
;
October 3, 2003
Animal Health News & Notes for September 26, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for September 26, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: ADM AgriLabs BASF Cotswold Swine Genetics DSM (Roche acquisition) DSM (BASF venture) First Priority IDEXX Maple Leaf Foods Merial Norbrook Labs Novartis Novozymes Oil Dri PIC Phibro AH Phoenix Scientific Quantum Genetics Roche Vitamins Seghers Newsham Genetics Smithfield Foods Veterinary Labs ******************************************************************** COMPANY EARNINGS RELEASES > Oil-Dri Corporation of America announced sales for fiscal year 2003 ended July 31 were $173 million, a 7% increase from sales for fiscal year 2002. Net income for the fiscal year was $3,083,000, a significant improvement from a net loss of ($1,094,000) for fiscal 2002. Contributing to the successful year the acquisition of Jonny Cat cat litter brand as well as the manufacturing and mining facilities in Taft, California, and the geographic reorganization strategy with the Wal-Mart Company to supply Special Kitty cat litter. (Business Wire) ******************************************************************** COMPANY NEWS RELEASES > Sygen International plc announced that its subsidiary, PIC, has reached binding agreement to acquire all product lines and key
;
September 26, 2003
Animal Health News & Notes for September 19, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for September 19, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Alpharma Cargill ConAgra Elanco Farmland Foods Frontier Beef Systems Heska MetaFarms Novartis Animal Vaccines Smithfield Pfizer (Canada) PPL Therapeutics VeriPrime ******************************************************************** COMPANY EARNINGS RELEASES > ConAgra Foods reported a 14% drop in first quarter profits as sales fell 33%, reflecting the sale of its fresh meat and other businesses. Net income was $195 million in the quarter ended Aug. 24 2003, compared with $228 million in the same period last year. Sales were $4.4 billion, compared with $6.6 billion last year. ConAgra sold its fresh beef and pork business in September last year, its canned seafood and cheese businesses in May and it plans to close on sale of its fresh chicken holdings in the second quarter. (AP) ******************************************************************** COMPANY NEWS RELEASES > Heska Corporation announced the introduction of the E.R.D.-HealthScreen Feline Urine Test, the first in-clinic test developed to identify early kidney damage which can be due to potentially undetected health problems in cats. The
;
September 19, 2003
Animal Health News & Notes for September 12, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for September 12, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Banfield Boehringer Ingelheim Butler Digital Angel DSM eMerge Interactive Formax Feeds King Pharmaceuticals Lifelearn Medallion Manufacturing Novartis Petosan Pfizer Roche Royal Canin Surebeam Virbac (King acquisition) Virbac (Equimax) ******************************************************************** COMPANY NEWS RELEASES > Virbac Corporation and King Pharmaceuticals, Inc. announced that Virbac has acquired the animal health products of King for $15.1 million in cash. The transaction includes certain product assets, unfilled customer orders, inventories, manufacturing equipment and intellectual property. The transaction supports Virbac’s expansion into the veterinary companion animal pharmaceutical market, and positions Virbac as a leader in the veterinary small animal endocrinology market segment. (Business Wire) > DSM announced that it will pay 200 million euros ($225 million) less for the acquisition of Roche’s Fine Vitamins and Chemicals division because of the division’s poor financial results in the first half of this year. The transaction price now stands at 1,750 million euros ($1,963 million). The division’s net sales at 1,020 million euros were 9%
;
September 12, 2003
Animal Health News & Notes for September 5, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for September 5, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** NEW IN THE NEWSLETTER: You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Advanced ID Alltech Banfield Hill’s Iams Omaha Steaks ******************************************************************** COMPANY NEWS RELEASES > Hill’s Pet Nutrition announced the launch of Science Diet Advanced Protection food for adult and senior dogs and cats. The majority of pet owners using the new diets for 30 days in an in-home trial reported increases in vitality and alertness. The diet contains a patent-pending combination of anti-oxidants and other natural ingredients that enhance the protective effects of antioxidants on cell membranes. (Veterinary Practice News) > Iams announced the launch of a free quarterly “Running with the Big Dogs” online newsletter for owners of large-breed dogs. Inside each issue are fun features on big dogs, tips on exercising with your pets, nutrition information, a Q&A section with a veterinarian answering specific questions about the unique needs of big dogs, special offers and more. While supplies last, big-dog owners also can request the free “Running with the Big Dogs”
;
September 5, 2003
Animal Health News & Notes for August 29, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for August 29, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** NEW IN THE NEWSLETTER: You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Advanstar Communications Alcide (earnings) aLF Ventures Bringyourpet.com Ceva Sante Animale (earnings) Farms Technology Heska Merial (scholarships) Merial (Bader Rutter) Nexia Biotechnologies PETsMART (earnings) Rooster.com Sanderson Farms (earnings) Strategic Diagnostics Thompson Corp. Trans Ova Genetics Veterinary Healthcare Communications ****************************************************************** COMPANY EARNINGS RELEASES > Ceva Sante Animale reported turnover of 102 million euros ($117 million) during the first 6 months of 2003, an increase of 6.5% compared to the same period last year. This growth is particularly linked to the good results of Europe that compensated for the rise in euro currency and the political and health problems that occurred in Middle East and Asia during this period. The Companion Animal (and particularly products for treatment of behavior problems) and anti-infectives ranges of the CEVA Group have shown good results during this first half of year 2003. (company information) > PETsMART, Inc. announced results for its second quarter ended August 4, 2003. The
;
August 29, 2003
Animal Health News & Notes for August 28, 2003 – 4th Anniversary Edition
printer friendly version **************************************************************** Brakke Consulting’s Animal Health News & Notes for August 28, 2003 Copyright © Brakke Consulting, Inc. **************************************************************** ANIMAL HEALTH NEWS & NOTES MARKS FOUR-YEAR ANNIVERSARY This week marks the four-year anniversary of Brakke Consulting’s weekly electronic newsletter, “Animal Health News & Notes.” Our subscriber list has grown to over 4,000 names from all aspects of the animal health, pet and veterinary professions around the globe. We are proud to be a leading source of timely news about the animal health industry. We hope that you find our newsletter useful, and that you will continue to pass it on to friends and colleagues within the industry. ******************************************************************* BRAKKE CONSULTING, INC. Serving the Worldwide Animal Health and Pet Care Industries Providing a complete range of consulting services, including: > General Management Consulting > Mergers, Acquisitions, Divestitures, Licensing > Industry Information and Market Research > Executive and Managerial Search > Veterinary Practice Management * Headquartered in Dallas, TX (972) 243-4033 * Other US Offices in Chicago, St. Louis, South Carolina, and Florida * International Offices in Osaka & Sydney ******************************************************************* NEW IN THE NEWSLETTER: The HTML version of Brakke Consulting Animal Health News & Notes now offers a new “jump to” section at the top of the newsletter, listing the names of the companies with items in the newsletter
;
August 28, 2003
Animal Health News & Notes for August 22, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for August 22, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** NEW IN THE NEWSLETTER: You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: BC Natural Foods Breeder’s Choice Central Garden & Pet Ceva Sante Animale Delmarva Labs IDEXX Lallemand Animal Nutrition Nestle (earnings) Nestle Purina PetCare Novartis Animal Vaccines Penn Valley Farms Pennfield Farms PETCO Animal Supplies (earnings) Pro Brands Ltd. Smithfield Foods (earnings) VCA Antech Virbac Corp. Webster Veterinary Supply (earnings) ****************************************************************** COMPANY EARNINGS RELEASES > Nestle reported that sales for the first half of 2003 for its Petcare division were 4,674 million CHF ($3.5 billion), down 13.5% compared to the first half of 2002. The company noted that the strength of the Swiss franc against other currencies had a significant unfavorable impact on results (12.6% on total company sales). Organic growth for the Petcare division was flat compared to the first half of 2002, and EBITA margins increased from 12.2% to 13.7%. (company website) > PETCO Animal Supplies, Inc. reported financial results for the second quarter ended August 2, 2003.
;
August 22, 2003
Animal Health News & Notes for August 15, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for August 15, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** NEW IN THE NEWSLETTER: You can now use this section to jump directly to a news item about a particular company. Simply click on the company name. To return to the top of the newsletter, use the scroll button on the right of your email window. JUMP TO: Alltech Bioniche Animal Health Cardinal Laboratories Fort Dodge Lallemand Merial Optibrand Pheromone Sciences Ridley Smithfield Foods Swift & Co. VetCentric Veterinary Information Network ****************************************************************** COMPANY NEWS RELEASES > Merial announced the introduction of Tetradure 300 (oxytetracycline) Injection, a prescription antibiotic labeled for cattle at high risk for Bovine Respiratory Disease (BRD) associated with Mannheimia (Pasteurella) haemolytica. When administered to high-risk cattle, new Tetradure 300 provides therapeutic blood levels of the active ingredient for seven to eight days. Tetradure 300 has been used successfully in Canada since 1998 on more than 1 million head of cattle. Tetradure 300 also effectively controls pinkeye and footrot. Tetradure 300 is available from licensed veterinarians and is labeled for use in beef, non-lactating dairy cattle and dairy calves. (company press release) > Some recent stories have suggested that the Fort Dodge Animal Health West Nile Virus Vaccine approved by the USDA may cause pregnant mares to
;
August 15, 2003
Animal Health News & Notes for August 8, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for August 8, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES > Bayer reported that sales of the Animal Health segment rose by 0.9% in the second quarter of 2003 to 214 million euros ($245 million). In local currencies, sales grew by 15.1%, helped by the successful US launch of K9 Advantix. EBIT for the second quarter 2003, at 45 million euros ($51.5 million), was a 4.7% increase over the second quarter of 2002. (company website) > Boehringer Ingelheim reported that first-half 2003 sales for its animal health division Boehringer Ingelheim Vetmedica were 151 million euros ($173 million), flat compared to the first half of 2002. (company website) > Virbac Corporation reported results for the second quarter and six months ended June 30, 2003. For the second quarter 2003, net sales set a record, rising 22% to $19.1 million from $15.6 million in the second quarter of 2002. Net income for the period was $1.2 million compared with $0.7 million in the second quarter of 2002. (Business Wire) > Sound Technologies reported first half results for Ultrasound, Education, and Consulting Business Units for the six months ended June 30, 2003. Sales increased 35.1% to $7.67 million, and income increased 68.7% to $906,899. The Company’s strong performance resulted from increased sales
;
August 8, 2003
Animal Health News & Notes for August 1, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for August 1, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES > Aventis reported results for the second quarter 2003 for its animal health division Merial. Sales by the Merial joint venture were 413 million euros ($472 million) in the second quarter, down 3% from the year-ago period on an activity basis. This figure includes Merial’s poultry genetics business. (company website) > Heska reported financial results for the second quarter of 2003. Total revenues for the second quarter were $14.8 million, compared to $12.2 million in the second quarter of 2002. Quarterly net loss decreased to ($7.4 million) from a net loss of ($7.8 million) in the second quarter of 2002. (company press release) > Tyson Foods reported results for the third fiscal quarter ended June 28, 2003. Third quarter sales were $6.3 billion compared to $5.9 billion for the same period last year. Sales in the beef segment for the third quarter were $3.15 billion compared to $2.7 billion in 2002. Sales in the chicken segment were $1.88 billion compared to $1.86 billion in 2002. Sales in the pork segment were $631 million compared to $552 million in 2002. (Meating Place) ******************************************************************** NOW AVAILABLE! VETERINARY DRUG COMPOUNDING STUDY In the past year or two, the exhibit halls at
;
August 1, 2003
Animal Health News & Notes for July 25, 2003
****************************************************************** Brakke Consulting’s Animal Health News & Notes for July 25, 2003 Copyright © Brakke Consulting, Inc. ****************************************************************** COMPANY EARNINGS RELEASES > Pfizer reported that second quarter 2003 sales for its animal health division increased 40% to $383 million. Pfizer completed its acquisition of Pharmacia on April 16, 2003. Using the combined sales for the two companies in the second quarter of 2002, sales declined 3%. Sales for the first half of 2003 were $652 million, an increase of 27% over Pfizer’s 2002 sales. (company website) > Wyeth reported that second quarter 2003 sales for its animal health division Fort Dodge were $214 million, a 10% increase compared to the second quarter of 2002. First half sales were $396 million, an 11% increase compared to the comparable period in the prior year. The increase in revenues was primarily due to domestic sales of its West Nile Innovator vaccine for horses. (company website) > Eli Lilly reported that second quarter 2003 sales of its animal health division Elanco were $166.5 million, an increase of 3% compared to the second quarter in the prior year. (company website) > Novartis reported that first half 2003 sales of its animal health division were $339 million, an 8% increase over the first half of 2002. Sales for the second quarter were $182 million. New products
;
July 25, 2003
Page 62 of 73
